Arcellx (ACLX) Assets Average (2022 - 2025)
Arcellx's (ACLX) quarterly Assets Average came in at $630.0 million in Q4 2025, down 14.65% year-on-year from $738.1 million in Q4 2024, and down 1.18% quarter-over-quarter from $637.5 million in Q3 2025.
Arcellx (ACLX) Assets Average (2022 - 2025) Analysis & Trends
Arcellx's Assets Average history runs 4 years deep, the most recent figure standing at $630.0 million for Q4 2025.
- On a quarterly basis, Assets Average fell 14.65% year-over-year to $630.0 million in Q4 2025; TTM through Dec 2025 was $630.0 million, a 14.65% decrease from a year earlier, with the FY2025 full-year figure at $657.7 million, down 14.39% from the prior year.
- Assets Average declined to $630.0 million in Q4 2025 per ACLX's latest filing, from $637.5 million in the prior quarter.
- Across five years, Assets Average topped out at $802.4 million in Q1 2024 and bottomed at $187.9 million in Q1 2022.
- The 4-year median for Assets Average is $631.8 million (2025), against an average of $577.4 million.
- Across the five-year window, Assets Average surged 149.29% in 2023 and slipped 16.3% in 2025, its largest moves.
- Year by year, Assets Average stood at $325.6 million in 2022, then surged by 121.05% to $719.7 million in 2023, then advanced by 2.56% to $738.1 million in 2024, then declined by 14.65% to $630.0 million in 2025.
- Per Business Quant, the three latest ACLX Assets Average figures stand at $630.0 million (Q4 2025), $637.5 million (Q3 2025), and $633.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 629.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 629.95 Mn |
| Sep 30, 2025 | 637.50 Mn |
| Jun 30, 2025 | 633.58 Mn |
| Mar 31, 2025 | 679.70 Mn |
| Dec 31, 2024 | 738.12 Mn |
| Sep 30, 2024 | 749.61 Mn |
| Jun 30, 2024 | 757.00 Mn |
| Mar 31, 2024 | 802.41 Mn |
| Dec 31, 2023 | 719.68 Mn |
| Sep 30, 2023 | 618.87 Mn |
| Jun 30, 2023 | 623.24 Mn |
| Mar 31, 2023 | 468.38 Mn |
| Dec 31, 2022 | 325.57 Mn |
| Sep 30, 2022 | 356.00 Mn |
| Jun 30, 2022 | 310.82 Mn |
| Mar 31, 2022 | 187.88 Mn |